SeraNovo is a global leader in pharmaceutical formulation innovation, specializing in enhancing the oral bioavailability of complex small molecules and peptides. Our proprietary technology unlocks the full potential of even the most challenging active ingredients, transforming them into viable therapeutic products.
Founded in 2017 and based in the Netherlands, SeraNovo has successfully addressed difficult formulation challenges for a diverse, global client base, helping to advance promising medical therapies toward clinical success.
Driven by a culture of innovation, SeraNovo's achievements are backed by a robust portfolio of intellectual property, ensuring our solutions remain at the forefront of pharmaceutical advancements.
Company Details
- Employees
- 13
- Founded
- 2017
- Address
- Leiden, Zuid-Holland 2333ch, Nl
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.seranovo.com
- Keywords
- Rotterdam.
- HQ
- Leiden, Zuid-Holland
Seranovo Questions
Seranovo's website is https://www.seranovo.com
Seranovo's LinkedIn profile is https://nl.linkedin.com/company/seranovo
Seranovo has
13 employees.
View email and phone details for 13
employees at Seranovo.
Seranovo's industry is
Pharmaceutical Manufacturing
Seranovo's top competitors are
Ardena,
Biosanapharma,
Atbtherapeutics,
Byondis,
Innocore Pharmaceuticals,
Incircular,
Proqr Therapeutics,
Polyvation,
Amarna Therapeutics,
Yg Studios.
Seranovo's categories are Pharmaceutical Manufacturing
Seranovo's founding year is 2017
